Skip to content

Ropivacaine-dexmedetomidine versus ropivacaine alone in peribulbar blocks

A prospective, randomized, triple-blind comparative study of ropivacaine-dexmedetomidine versus ropivacaine alone in peribulbar blocks

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023951
Enrollment
80
Registered
2020-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract Health Condition 2: H259- Unspecified age-related cataract

Interventions

Control Intervention1: Ropivacaine 0.75% plus dexmedetomidine 10 µg ,15µgand 20 µg in groups RD1,RD2 and RD3 respectively: six ml of 0.75% Ropivacaine plus 10 µg DMT in group RD1, six ml of 0

Sponsors

Gayatri vidya parishad Institute of health care and medical technology
Lead Sponsor
Gayatri Vidya Parishad Institute of Health Care and Medical Technology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for our study consist of both male and female patients with an age range between 40 and 80 years and are of American Society of Anesthesiologists (ASA) physical status grades I and II attending our medical college hospital for elective cataract surgery.

Exclusion criteria

Exclusion criteria: The exclusion criteria for our study include patients with known allergy to study drugs, those refusing the regional block, those on anticoagulant therapy, high myopia (axial length of eyeball > 28 mm), previous ophthalmic surgery such as buckling surgery, glaucoma, posterior staphyloma, ocular infection, orbital anomaly, mental retardation, uncontrolled hypertension & diabetes mellitus, and chronic obstructive pulmonary disease.

Design outcomes

Primary

MeasureTime frame
The primary outcome measures observed were the duration of the onset of the motor and sensory block and total duration of the sensory block.Timepoint: Onset of sensory block is assessed when there is complete loss of sensation in the eye. Onset of motor block is assessed when there is complete loss of movement of the eyeball. Total duration of sensory block is assessed when patient complains of pain in the eye.

Secondary

MeasureTime frame
Alterations in mean arterial pressure (MAP), pulse rate (PR), respiratory rate (RR), saturation of arterial oxygen (SaO2), adverse drug effects, total analgesic requirement in the first 24 hours after surgery, Ramsay sedation score(RSS), surgeon and patient satisfaction scores and other complications encountered were the secondary outcome measures studied.Timepoint: starting 1 minute from the administration of the block at1 minute interval upto 10 minutes and there after upto first 24 hours of completion of surgery

Countries

India

Contacts

Public ContactRamana Reddy MV

Gayatri Vidya Parishad Institute of Health Care and Medical Technology

drramanareddymoolagani@gmail.com9908232415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026